[Moxifloxacin and hepatic toxicity].
Franco Hidalgo
Silvia
S
Prieto de Paula
José María
JM
García Lorenzo
Raquel
R
Salado Valdivieso
Inés
I
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001372:Aza Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D002780:Cholestasis, Intrahepatic / Q000209:etiology; D024841:Fluoroquinolones; D006801:Humans; D008297:Male; D015523:Maxillary Sinusitis / Q000188:drug therapy; D000077266:Moxifloxacin; D011804:Quinolines / Q000009:adverse effects* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin